We are live on
!
Find out more
DZ Bank Portfolio holdings
AUM
$113B
1-Year Est. Return
36.92%
This Fund
S&P 500
This Quarter
Est. Return
-1.28%
1 Year Est. Return
+36.92%
3 Year Est. Return
+150.91%
5 Year Est. Return
+223.96%
10 Year Est. Return
–
AUM
$70.4B
AUM Growth
+$3.85B
(+5.8%)
Cap. Flow
+$4.62B
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
34.8%
Holding
1,088
New
69
Increased
276
Reduced
305
Closed
107
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$1.1B |
| 2 |
UnitedHealth
UNH
|
+$936M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$755M |
| 4 |
Oracle
ORCL
|
+$638M |
| 5 |
Humana
HUM
|
+$605M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$566M |
| 2 |
Accenture
ACN
|
+$454M |
| 3 |
PPG Industries
PPG
|
+$430M |
| 4 |
Coca-Cola
KO
|
+$421M |
| 5 |
Advanced Micro Devices
AMD
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.89% |
| 2 | Healthcare | 16.66% |
| 3 | Financials | 10.28% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.83T
| $4.85B | 6.9% |
15,375,541
+1,013,043
| +7% | +$335M |
|
2
Apple
AAPL
$4.72T
| $3.78B | 5.37% |
22,063,232
+492,792
| +2% | +$90.4M |
|
3
NVIDIA
NVDA
$5.06T
| $2.99B | 4.25% |
68,808,560
+2,451,560
| +4% | +$110M |
|
4
Alphabet (Google) Class A
GOOGL
$3.89T
| $2.53B | 3.59% |
19,317,855
+1,139,233
| +6% | +$147M |
|
5
Amazon
AMZN
$2.51T
| $2.1B | 2.99% |
16,540,754
+1,043,655
| +7% | +$140M |
|
6
JPMorgan Chase
JPM
$930B
| $1.9B | 2.71% |
13,132,246
-276,159
| -2% | -$41.4M |
|
7
Eli Lilly
LLY
$1.06T
| $1.84B | 2.62% |
3,430,932
+429,783
| +14% | +$221M |
|
8
Meta Platforms (Facebook)
META
$1.54T
| $1.67B | 2.37% |
5,564,290
+380,776
| +7% | +$115M |
|
9
Linde
LIN
$234B
| $1.42B | 2.02% |
3,821,408
-868,703
| -19% | -$331M |
|
10
Procter & Gamble
PG
$342B
| $1.39B | 1.98% |
9,553,212
+2,661,358
| +39% | +$407M |
|
|
11
UnitedHealth
UNH
$385B
| $1.38B | 1.95% |
2,728,356
+1,902,269
| +230% | +$936M |
|
|
12
Thermo Fisher Scientific
TMO
$213B
| $1.27B | 1.81% |
2,510,578
+1,417,175
| +130% | +$755M |
|
13
Merck
MRK
$322B
| $1.22B | 1.73% |
11,810,127
+1,010,671
| +9% | +$109M |
|
14
Boston Scientific
BSX
$64.8B
| $1.18B | 1.67% |
22,298,154
+806,030
| +4% | +$42.3M |
|
|
15
CRH
CRH
$65.5B
| $1.06B | 1.51% |
19,399,132
+19,319,132
| +24,149% | +$1.1B |
|
16
McDonald's
MCD
$187B
| $1.02B | 1.45% |
3,881,493
-15,260
| -0.4% | -$4.35M |
|
17
Eaton
ETN
$161B
| $1.02B | 1.45% |
4,780,574
-112,873
| -2% | -$24.3M |
|
18
Walmart Inc
WMT
$863B
| $992M | 1.41% |
18,601,623
+764,970
| +4% | +$40.7M |
|
19
Tesla
TSLA
$1.26T
| $945M | 1.34% |
3,775,130
+1,712,645
| +83% | +$440M |
|
20
ServiceNow
NOW
$95.1B
| $829M | 1.18% |
7,413,680
+1,894,515
| +34% | +$216M |
|
21
Applied Materials
AMAT
$447B
| $794M | 1.13% |
5,736,487
+3,844,299
| +203% | +$551M |
|
22
Mastercard
MA
$469B
| $794M | 1.13% |
2,005,450
+92,709
| +5% | +$37.2M |
|
23
Broadcom
AVGO
$1.87T
| $790M | 1.12% |
9,514,650
+6,676,780
| +235% | +$579M |
|
24
Visa
V
$669B
| $786M | 1.12% |
3,415,749
+1,679,222
| +97% | +$404M |
|
25
Wells Fargo
WFC
$261B
| $744M | 1.06% |
18,204,134
+2,663,072
| +17% | +$115M |
|
Similar funds
VAM
DZ Bank's Q3 2023 Portfolio in Review
As of Q3 2023, DZ Bank held 1,088 positions worth $70.4B, up 5.8% from $66.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
DZ Bank deployed $4.62B of net new capital in Q3 2023, opening 69 new positions and adding to 276 existing holdings. Its largest new stake was Kenvue: 1,406,267 shares worth $28.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $566M trimmed.
- DZ Bank's largest Q3 2023 buy was Kenvue: 1,406,267 shares worth $28.2M.
- DZ Bank added most to CRH in Q3 2023, an estimated $1.1B increase.
- DZ Bank's biggest Q3 2023 reduction was Edwards Lifesciences, cutting an estimated $566M.
- DZ Bank fully exited Zimmer Biomet in Q3 2023, selling an estimated $52M.
- DZ Bank's ten largest holdings make up 35% of its $70.4B portfolio in Q3 2023.
- DZ Bank opened 69 new positions and closed 107 in Q3 2023.
- DZ Bank's portfolio value rose 5.8% quarter-over-quarter to $70.4B.
Based on DZ Bank's 13F filing for Q3 2023, filed 14 Nov 2023.